Colonna, M. & Butovsky, O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev. Immunol. 35, 441–468 (2017).
Borst, K., Dumas, A. A. & Prinz, M. Microglia: Immune and non-immune functions. Immunity 54, 2194–2208 (2021).
Lane-Donovan, C., Paredes, M. & Kao, A. W. The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases. Prog. Neurobiol. 255, 102854 (2025).
Wake, H., Moorhouse, A. J. & Nabekura, J. Functions of microglia in the central nervous system-beyond the immune response. Neuron Glia Biol. 7, 47–53 (2011).
Michell-Robinson, M. A. et al. Roles of microglia in brain development, tissue maintenance and repair. Brain 138, 1138–1159 (2015).
Bohlen, C. J., Friedman, B. A., Dejanovic, B. & Sheng, M. Microglia in Brain Development, Homeostasis, and Neurodegeneration. Annu. Rev. Genet. 53, 263–288 (2019).
Van Acker, Z. P., Perdok, A., Bretou, M. & Annaert, W. The microglial lysosomal system in Alzheimer’s disease: Guardian against proteinopathy. Ageing Res Rev. 71, 101444 (2021).
Kim, Y., Ha, T.-Y., Lee, M.-S. & Chang, K.-A. Regulatory mechanisms and therapeutic implications of lysosomal dysfunction in Alzheimer’s disease. Int J. Biol. Sci. 21, 1014–1031 (2025).
Paumier, J.-M. & Gowrishankar, S. Disruptions in axonal lysosome transport and its contribution to neurological disease. Curr. Opin. Cell Biol. 89, 102382 (2024).
Ferguson, S. M. Neuronal lysosomes. Neurosci. Lett. 697, 1–9 (2019).
Spencer, J. I., Sudarikova, Y. & Devine, M. J. Non-canonical roles of lysosomes in neurons. Trends Neurosci S0166-2236(25)00222-X https://doi.org/10.1016/j.tins.2025.10.009 (2025).
Quick, J. D. et al. Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration. J. Neuroinflamm. 20, 185 (2023).
Wang, B. et al. TFEB–vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy. Nat. Neurosci. 27, 48–62 (2024).
Ballabio, A. & Bonifacino, J. S. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101–118 (2020).
Lawrence, R. E. & Zoncu, R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat. Cell Biol. 21, 133–142 (2019).
Bond, C., Hugelier, S., Xing, J., Sorokina, E. M. & Lakadamyali, M. Heterogeneity of late endosome/lysosomes shown by multiplexed DNA-PAINT imaging. J. Cell Biol. 224, e202403116 (2025).
Yu, Y. et al. Organelle proteomic profiling reveals lysosomal heterogeneity in association with longevity. Elife 13, e85214 (2024).
Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473–477 (2009).
Puertollano, R., Ferguson, S. M., Brugarolas, J. & Ballabio, A. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J. 37, e98804 (2018).
Gu, Z. et al. TFEB in Alzheimer’s disease: From molecular mechanisms to therapeutic implications. Neurobiol. Dis. 173, 105855 (2022).
Tan, A., Prasad, R., Lee, C. & Jho, E. Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell Death Differ. 29, 1433–1449 (2022).
Iyer, H., Shen, K., Meireles, A. M. & Talbot, W. S. A lysosomal regulatory circuit essential for the development and function of microglia. Sci. Adv. 8, eabp8321 (2022).
Shen, K., Sidik, H. & Talbot, W. S. The Rag-Ragulator complex regulates lysosome function and phagocytic flux in microglia. Cell Rep. 14, 547–559 (2016).
Yadavalli, N. & Ferguson, S. M. LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition. Proc. Natl. Acad. Sci. USA 120, e2303789120 (2023).
Gao, Y. et al. Comprehensive proteome analysis of lysosomes reveals the diverse function of macrophages in immune responses. Oncotarget 8, 7420–7440 (2017).
Filipello, F. et al. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss-of-function mutation. Acta Neuropathol. 145, 749–772 (2023).
Ulland, T. K. & Colonna, M. TREM2 — a key player in microglial biology and Alzheimer’s disease. Nat. Rev. Neurol. 14, 667–675 (2018).
Deczkowska, A., Weiner, A. & Amit, I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181, 1207–1217 (2020).
Heneka, M. T. et al. Neuroinflammation in Alzheimer disease. Nat. Rev. Immunol. 25, 321–352 (2025).
Barrella, L. et al. Targeting lysosomal acidification to restore microglial homeostasis and mitigate memory decline during male brain ageing. Brain Behav. Immun. 131, 106170 (2025).
Albertini, G. et al The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia. Nat. Neurosci. https://doi.org/10.1038/s41593-025-02125-8 (2025).
De Duve, C. Lysosomes revisited. Eur. J. Biochem. 137, 391–397 (1983).
Trivedi, P. C., Bartlett, J. J. & Pulinilkunnil, T. Lysosomal Biology and Function: Modern View of Cellular Debris Bin. Cells 9, 1131 (2020).
Yoshiyama, Y., Arai, K., Oki, T. & Hattori, T. Expression of invariant chain and pro-cathepsin L in Alzheimer’s brain. Neurosci. Lett. 290, 125–128 (2000).
Lowry, J. R. & Klegeris, A. Emerging roles of microglial cathepsins in neurodegenerative disease. Brain Res. Bull. 139, 144–156 (2018).
Nakanishi, H. Cathepsin regulation on microglial function. Biochim. Biophys. Acta (BBA) – Proteins Proteom. 1868, 140465 (2020).
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B. & Isidoro, C. The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders. Med. Res. Rev. 36, 845–870 (2016).
Jiang, M. et al. Cathepsin B modulates microglial migration and phagocytosis of amyloid β in Alzheimer’s disease through PI3K-Akt signaling. Neuropsychopharmacol 50, 640–650 (2025).
Mueller-Steiner, S. et al. Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer’s Disease. Neuron 51, 703–714 (2006).
Kingham, P. J. & Pocock, J. M. Microglial secreted cathepsin B induces neuronal apoptosis. J. Neurochem. 76, 1475–1484 (2001).
Terada, K. et al. Involvement of cathepsin B in the processing and secretion of interleukin-1β in chromogranin A-stimulated microglia. Glia 58, 114–124 (2010).
Ni, J. et al. Increased expression and altered subcellular distribution of cathepsin B in microglia induce cognitive impairment through oxidative stress and inflammatory response in mice. Aging Cell 18, e12856 (2019).
Gan, L. et al. Identification of Cathepsin B as a mediator of neuronal death induced by Aβ-activated microglial cells using a functional genomics approach. J. Biol. Chem. 279, 5565–5572 (2004).
Ryan, R. E., Sloane, B. F., Sameni, M. & Wood, P. L. Microglial Cathepsin B: An Immunological Examination of Cellular and Secreted Species. J. Neurochem. 65, 1035–1045 (1995).
Xu, S., Zhang, H., Yang, X., Qian, Y. & Xiao, Q. Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-κB pathways. Neurobiol. Aging 62, 159–167 (2018).
Liu, J. et al. Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. J. Proteome Res. 7, 2033–2049 (2008).
Kim, S. et al. Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J. Neurochem. 103, 2640–2650 (2007).
Takenouchi, T. et al. The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1β under acidic extracellular pH in LPS-primed microglial cells: P2X7 mediates p20-IL-1β production in microglia. J. Neurochem. no-no https://doi.org/10.1111/j.1471-4159.2011.07240.x (2011).
Holness, C. L., Da Silva, R. P., Fawcett, J., Gordon, S. & Simmons, D. L. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268, 9661–9666 (1993).
Micklem, K. et al. A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Br. J. Haematol. 73, 6–11 (1989).
Holness, C. & Simmons, D. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81, 1607–1613 (1993).
Rabinowitz, S. S. & Gordon, S. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. Exp. Med. 174, 827–836 (1991).
De Beer, M. C., Zhao, Z., Webb, N. R., Van Der Westhuyzen, D. R. & De Villiers, W. J. S. Lack of a direct role for macrosialin in oxidized LDL metabolism. J. Lipid Res. 44, 674–685 (2003).
Ramprasad, M. P., Terpstra, V., Kondratenko, N., Quehenberger, O. & Steinberg, D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 93, 14833–14838 (1996).
da Silva, R. P. & Gordon, S. Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein. Biochem J. 338, 687–694 (1999).
Chistiakov, D. A., Killingsworth, M. C., Myasoedova, V. A., Orekhov, A. N. & Bobryshev, Y. V. CD68/macrosialin: not just a histochemical marker. Lab. Investig. 97, 4–13 (2017).
Ramprasad, M. P. et al. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc. Natl. Acad. Sci. USA. 92, 9580–9584 (1995).
Kreipe, H., Radzun, H. J., Parwaresch, M. R., Haislip, A. & Hansmann, M. L. Ki-M7 monoclonal antibody specific for myelomonocytic cell lineage and macrophages in human. J. Histochem. Cytochem. 35, 1117–1126 (1987).
Bornemann, K. D. et al. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158, 63–73 (2001).
Ayata, P. et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat. Neurosci. 21, 1049–1060 (2018).
Hendrickx, D. A. E., Van Eden, C. G., Schuurman, K. G., Hamann, J. & Huitinga, I. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J. Neuroimmunol. 309, 12–22 (2017).
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V. & Bazinet, R. P. Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review. Mol. Psychiatry 23, 177–198 (2018).
Nicoll, J. A. R. et al. Aβ Species Removal After Aβ42 Immunization. J. Neuropathol. Exp. Neurol. 65, 1040–1048 (2006).
Wong, A. M. et al. Macrosialin increases during normal brain aging are attenuated by caloric restriction. Neurosci. Lett. 390, 76–80 (2005).
Tsering, W. et al. Preferential clustering of microglia and astrocytes around neuritic plaques during progression of Alzheimer’s disease neuropathological changes. J. Neurochem. 169, e16275 (2025).
Wharton, S. B., Simpson, J. E., Brayne, C. & Ince, P. G. Age-Associated White Matter Lesions: The MRC cognitive function and aging study. Brain Pathol. 25, 35–43 (2015).
Waller, R. et al. Iba-1-/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions. PLoS ONE 14, e0210888 (2019).
Simon, M. J., Logan, T., DeVos, S. L. & Di Paolo, G. Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia. Trends Cell Biol. 33, 324–339 (2023).
Rhinn, H., Tatton, N., McCaughey, S., Kurnellas, M. & Rosenthal, A. Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol. Sci. 43, 641–652 (2022).
Götzl, J. K. et al. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice. Mol. Neurodegen. 13, 48 (2018).
Pickford, F. et al. Progranulin Is a Chemoattractant for microglia and stimulates their endocytic activity. Am. J. Pathol. 178, 284–295 (2011).
Minami, S. S. et al. Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models. Nat. Med 20, 1157–1164 (2014).
Mishra, S. et al. The Alzheimer’s Disease Gene SORL1 Regulates Lysosome Function in Human Microglia. Glia 73, 1329–1348 (2025).
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet 45, 1452–1458 (2013).
Schmidt, V., Subkhangulova, A. & Willnow, T. E. Sorting receptor SORLA: cellular mechanisms and implications for disease. Cell. Mol. Life Sci. 74, 1475–1483 (2017).
Hung, C. et al. SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network. Cell Rep. 35, 109259 (2021).
Masrori, P. et al. C9orf72 hexanucleotide repeat expansions impair microglial response in ALS. Nat. Neurosci. 28, 2217–2230 (2025).
Haeusler, A. R., Donnelly, C. J. & Rothstein, J. D. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 17, 383–395 (2016).
Amick, J. & Ferguson, S. M. C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease. Traffic 18, 267–276 (2017).
Lee, J.-H. et al. Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations. Cell 141, 1146–1158 (2010).
Zhang, Y. et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci. 34, 11929–11947 (2014).
Bustos, V. et al. Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome–lysosome fusion. Proc. Natl. Acad. Sci. USA 114, 7148–7153 (2017).
Majumder, P. et al. AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network. MBoC 33, ar102 (2022).
Orlowski, A. et al. Axonal Organelle Buildup from Loss of AP-4 Complex Function Causes Exacerbation of Amyloid Plaque Pathology and Gliosis in Alzheimer’s Disease Mouse Model. eNeuro 11, ENEURO.0445-24.2024 (2024).
Meyer, H. & Kravic, B. The Endo-Lysosomal Damage Response. Annu Rev. Biochem 93, 367–387 (2024).
Gómez-Sintes, R., Ledesma, M. D. & Boya, P. Lysosomal cell death mechanisms in aging. Ageing Res Rev. 32, 150–168 (2016).
Zoncu, R. & Perera, R. M. Built to last: lysosome remodeling and repair in health and disease. Trends Cell Biol. 32, 597–610 (2022).
Scott, O., Saran, E. & Freeman, S. A. The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation. EMBO Rep. 26, 1425–1439 (2025).
Smith, E. M., Chanaday, N. L. & Maday, S. Astrocytes mobilize a broader repertoire of lysosomal repair mechanisms than neurons. bioRxiv 2025.09.07.674666 https://doi.org/10.1101/2025.09.07.674666 (2025).
Chou, C.-C. et al. Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease. Nat. Cell Biol. 27, 619–632 (2025).
Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857–865 (2008).
Wootz, H., Weber, E., Korhonen, L. & Lindholm, D. Altered distribution and levels of cathepsin D and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival. Neuroscience 143, 419–430 (2006).
Bussi, C. et al. Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells. J. Cell Sci. 131, jcs226241 (2018).
Masuda, T., Sankowski, R., Staszewski, O. & Prinz, M. Microglia Heterogeneity in the Single-Cell Era. Cell Rep. 30, 1271–1281 (2020).
Dadwal, S. & Heneka, M. T. Microglia heterogeneity in health and disease. FEBS Open Bio 14, 217–229 (2024).
Healy, L. M., Zia, S. & Plemel, J. R. Towards a definition of microglia heterogeneity. Commun. Biol. 5, 1114 (2022).
Lawson, L. J., Perry, V. H., Dri, P. & Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151–170 (1990).
De Biase, L. M. et al. Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia. Neuron 95, 341–356.e6 (2017).
Schmid, C. D. et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J. Neurochem. 83, 1309–1320 (2002).
Burns, J. C. et al. Differential accumulation of storage bodies with aging defines discrete subsets of microglia in the healthy brain. eLife 9, e57495 (2020).
Chavan, I. & Bhattacharjee, A. Lysosome heterogeneity and diversity mapped through its distinct cellular functions. Cell Mol. Life Sci. 82, 380 (2025).
Yap, C. C., Mason, A. J. & Winckler, B. Dynamics and distribution of endosomes and lysosomes in dendrites. Curr. Opin. Neurobiol. 74, 102537 (2022).
El Hajj, H. et al. Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology. J. Neuroinflamm. 16, 87 (2019).
Yin, B. et al. Automated spatially targeted optical microproteomics investigates inflammatory lesions in situ. J. Proteome Res. 20, 4543–4552 (2021).